SCHEMBL9250319

SCHEMBL9250319

CCCC[C@H]1CC[C@H](c2ccc(-c3cc(F)c(F)cc3F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.41
ESR2 Q92731 3/20 0.40
CYP3A4 P08684 4/20 0.39
MEN1 O00255 2/20 0.39
MAPK1 P28482 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
APP P05067 2/20 0.37
SPHK1 Q9NYA1 5/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
ESR1 P03372 1/20 0.36
GAA P10253 1/20 0.35
DGAT1 O75907 1/20 0.35
SOAT1 P35610 1/20 0.35
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9251492 0.96 CYP2C9 (0.40) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9251474 0.95 SPHK1 (0.40) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9252920 0.95 SPHK1 (0.40) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9252916 0.95 SPHK1 (0.40) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9255003 0.92 CYP2C9 (0.49) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL27081818 0.90 CYP2C9 (0.40) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL11113415 0.89 CYP2C9 (0.44) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL11113421 0.89 CYP2C9 (0.44) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9260515 0.87 CYP2C9 (0.43) CYP2C9ESR2CYP3A4MEN1MAPK1
SCHEMBL9260523 0.87 CYP2C9 (0.43) CYP2C9ESR2CYP3A4MEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995009828-A1 2,4,5-TRIFLUOROBENZENES AND THEIR USE IN LIQUID CRYSTAL MIXTURES MERCK PATENT GMBH (DE) 1995-04-13 WO disclosed